Carotid Web and Stroke Registry.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-15

Study Completion Date

2025-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction:

Carotid Web (CW) is a common cause of stroke in young patients with a high recurrence rate. The factors associated with recurrences and the appropriate treatment to prevent them are currently unknown.

Main objective:

To compare recurrences of ischemic stroke (cerebral infarction or transient ischemic attack) in patients with CW according to the preventive treatment.

Secondary objectives:

* To describe the frequency of recurrences in patients with stroke and CW.
* To compare the risk of complications, especially hemorrhagic complications, in patients with stroke and CW according to the type of preventive treatment given.
* To describe the clinical and radiological characteristics of CW and identify which are associated with recurrences.
* To detect genetic polymorphisms associated with the presence of CW in stroke patients.

Study design:

Multicenter, prospective registry of consecutive cases with ischemic stroke in which a Carotid Web is detected between 2022 and 2024.

All patients with ischemic stroke or transient ischemic attack and age \> or = 18 years, in whom a Carotid Web is diagnosed, will be included. Demographic and clinical variables, genetic study (not mandatory), diagnostic methods of CW, reperfusion treatment and secondary prevention will be collected. During a minimum follow-up of six months, vascular events (stroke, transient ischemic accidents, cerebral hemorrhages) and treatments (antiplatelet therapy, anticoagulation, endarterectomy, endovascular therapy) will be collected.

Once the registry has been completed, the frequency of recurrences and the factors associated with them will be analyzed.

Study population:

Patients with ischemic stroke or transient ischemic attack in whom a Carotid Web is detected. It is estimated to obtain data from approximately 100 patients.

Variables:

Demographic, clinical (past medical history, stroke characteristics), radiological (diagnostic method of CW, morphological characteristics of CW), therapeutic (preventive treatment initiated) and prognostic variables will be collected. Recurrences in the form of stroke or transient ischemic attack (main variable) will be collected during a minimum follow-up of six months. Cerebral hemorrhages, mortality and therapeutic changes during follow-up will also be collected.

Ethical considerations:

This is an observational registry, with no changes in the management or treatment of the patients included, and with an anonymized data registry. Written informed consent will be requested from the patient or his/her representative for participation in the registry and for obtaining a blood sample for the genetic study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

"Carotid Web Incidence and Radiological Classification, Determination of Its Relationship With Ischemic Stroke"

NCT06058507

Stroke Transient Ischemic Attack Carotid Artery Diseases

COMPLETED

Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke

NCT05645081

Stroke, Ischemic Transient Ischemic Attack Coagulation Disorder

RECRUITING

Neurothrombectomy France

NCT02880579

Cerebral Artery Occlusion

COMPLETED

Thromboelastometry and Ischemic Stroke (ThromboPredict)

NCT04870684

Cerebrovascular Stroke Thrombolytic Therapy Mechanical Thrombectomy

UNKNOWN

Retrospective Study of Intracerebral Hemorrhage Patients in Hospital Parc Taulí

NCT04877405

Intracerebral Hemorrhage

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Carotid Web

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Antiplatelet

Antiplatelet Drug

Intervention Type DRUG

Any antiplatelet drug or combination

Anticoagulant

Intervention Type DRUG

Any anticoagulante

Endovascular

Intervention Type PROCEDURE

Angioplasty +- stent

Surgical (endarterectomy)

Surgery

Intervention Type PROCEDURE

Endarterectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Antiplatelet Drug

Any antiplatelet drug or combination

Intervention Type DRUG

Anticoagulant

Any anticoagulante

Intervention Type DRUG

Endovascular

Angioplasty +- stent

Intervention Type PROCEDURE

Surgery

Endarterectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with ischemic stroke or TIA and
* Age \> or = 18 years.
* Carotid Web diagnosed by angioCT, angioMRI or arteriography.
* Consent to participate from patient or representative